Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IκB kinase

Biochemical Pharmacology

Volumn 73, Issue 2, 2007, Pages 237-247

  Park, Hye Ji ^a   Son, Dong Ju ^a   Lee, Chung Woo ^a   Choi, Myoung Suk ^a   Lee, Ung Soo ^b   Song, Ho Sueb ^c   Lee, Jeong Min ^d   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Chungju National University   (South Korea)

^c Gachon University College of Medicine   (South Korea)

^d Sinil Pharmaceutical Co Ltd   (South Korea)

Author keywords

Bee venom; IKK; Inflammation; Melittin; NF B

Indexed keywords

BEE VENOM; CYCLOOXYGENASE 2; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; LIPOPOLYSACCHARIDE; MELITTIN; MUTANT PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SURFACE PLASMON RESONANCE; SYNOVIOCYTE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; MELITTEN; MICE; PROTEIN BINDING; SURFACE PLASMON RESONANCE;

EID: 33845365197     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.09.023     Document Type: Article

References (37)

1. Baeuerle P.A. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 95 (1998) 729-731
2. O'Connell M.A., Bennett B.L., Mercurio F., Manning A.M., and Mackman N.J. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 46 (1998) 30410-30414
3. Magnani M., Crinelli R., Bianchi M., and Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr Drug Targets 1 (2000) 387-399
4. Karin M., and Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 12 (2000) 85-98
5. Tak P.P., Gerlag D.M., Aupperle K.R., Geest D.A., Overbeek M., Bennett B.L., et al. Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 44 (2001) 1897-1907
6. Jeon K.I., Byun M.S., and Jue D.M. Gold compound auranofin inhibits IkappaB kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med 35 (2003) 61-66
7. Cuzzocrea S., Wayman N.S., Mazzon E., Dugo L., Di Paola R., erraino I., et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol 61 (2002) 997-1007
8. Kapahi P., Takahashi T., Natoli G., Adams S.R., Chen Y., Tsien R.Y., et al. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J Biol Chem 275 (2002) 36062-36066
9. Billingham M.E., Morley J., Hanson J.M., Shipolini R.A., and Vernon C.A. Letter: an anti-inflammatory peptide from bee venom. Nature 245 (1973) 163-164
10. Kwon Y.B., Lee J.D., Lee H.J., Han H.J., Mar W.C., Kang S.K., et al. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 90 (2001) 271-280
11. Perez-Paya E., Houghten R.A., and Blondelle S.E. The role of amphipathicity in the folding, self-association and biological activity of multiple subunit small proteins. J Biol Chem 270 (1995) 1048-1056
12. Park H.J., Lee S.H., Son D.J., Oh K.W., Kim K.H., Song H.S., et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum 50 (2004) 3504-3515
13. Lee J.H., Koo T.H., Hwang B.Y., and Lee J.J. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 277 (2002) 18411-18420
14. Jeon Y.J., Kim Y.K., Lee M., Park S.M., Han S.B., and Kim H.M. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 294 (2000) 548-554
15. Haridas V., Arntzen C.J., and Gutterman J.U. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-B by inhibiting both its nuclear localization and ability to bind DNA. Proc Natl Acad Sci 98 (2001) 11557-11562
16. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci 90 (1993) 7240-7244
17. Guastadisegni C., Nicolini A., Balduzzi M., Ajmone-Cat M.A., and Minghetti L. Modulation of PGE(2) and TNFalpha by nitric oxide and LPS-activated RAW 264.7 cells. Cytokine 19 (2002) 175-180
18. Pelletier J.P., Jovanovic D., Fernandes J.C., Manning P., Connor J.R., Currie M.G., et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41 (1998) 1275-1286
19. Yang Y., Hutchinson P., and Morand E.F. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 42 (1999) 1538-1544
20. Longo W.E., Panesar N., Mazuski J., and Kaminski D.L. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. Prostagland Other Lipid Mediat 56 (1994) 325-330
21. Jeon K.I., Jeong J.Y., and Jue D.M. Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J Immunol 164 (2000) 5981-5989
22. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper FN.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1998) 315-324
23. Grisham M.B., Johnson G.G., and Lancaster J.R. Quantitation of nitrate and nitrite in extracellular fluids. Meth Enzymol 268 (1996) 237-246
24. Akiba S., Hatazawa R., Ono K., Kitatani K., Hayama M., and Sato T. Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic hospholipase A2 expression in rat gastric epithelial cells. J Biol Chem 276 (2001) 21854-21862
25. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
26. Rich R.L., Hoth L.R., Geoghegan K.F., Brown T.A., LeMotte P.K., Simons S.P., et al. Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci 99 (2002) 8562-8567
27. Corr M., Slanetz A.E., Boyd L.F., Jelonek M.T., Khilko S., al-Ramadi B.K., et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265 (1994) 946-949
28. Cernuda-Morollon E., Pineda-Molina E., Canada F.J., and Perez-Sala D. 15-Deoxy-delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 276 (2001) 35530-35536
29. Saini S.S., Peterson J.W., and Chopra A.K. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity. Biochem Biophys Res Commun 238 (1997) 436-442
30. Mingarro I., Perez-Paya E., Pinilla C., Appel J.R., Houghten R.A., and Blondelle S.E. Activation of bee venom phospholipase A2 through a peptide-enzyme complex. FEBS Lett 327 (1995) 131-134
31. Warner T.D., and Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 (2004) 790-804
32. Bertolini A., Ottani A., and Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr Med Chem 9 (2002) 1033-1043
33. Nguyen H.X., and Tidball J.G. Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice. J Physiol 550 (2003) 347-356
34. Abramson S.B., Attur M., Amin A.R., and Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3 (2001) 535-541
35. 2 and TNF-α by nitric oxide in resting and LPS activated Raw 264.7 cells. Cytokine 19 (2002) 175-180
36. Abramson S.B., Amin A.R., Clancy R.M., and Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15 (2001) 831
37. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20